Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Sep 20:14:1251645.
doi: 10.3389/fimmu.2023.1251645. eCollection 2023.

Clinical applications of radiomics in non-small cell lung cancer patients with immune checkpoint inhibitor-related pneumonitis

Affiliations
Review

Clinical applications of radiomics in non-small cell lung cancer patients with immune checkpoint inhibitor-related pneumonitis

Yang Shu et al. Front Immunol. .

Abstract

Immune checkpoint inhibitors (ICIs) modulate the body's immune function to treat tumors but may also induce pneumonitis. Immune checkpoint inhibitor-related pneumonitis (ICIP) is a serious immune-related adverse event (irAE). Immunotherapy is currently approved as a first-line treatment for non-small cell lung cancer (NSCLC), and the incidence of ICIP in NSCLC patients can be as high as 5%-19% in clinical practice. ICIP can be severe enough to lead to the death of NSCLC patients, but there is a lack of a gold standard for the diagnosis of ICIP. Radiomics is a method that uses computational techniques to analyze medical images (e.g., CT, MRI, PET) and extract important features from them, which can be used to solve classification and regression problems in the clinic. Radiomics has been applied to predict and identify ICIP in NSCLC patients in the hope of transforming clinical qualitative problems into quantitative ones, thus improving the diagnosis and treatment of ICIP. In this review, we summarize the pathogenesis of ICIP and the process of radiomics feature extraction, review the clinical application of radiomics in ICIP of NSCLC patients, and discuss its future application prospects.

Keywords: deep learning; immune checkpoint inhibitor-related pneumonitis; immunotherapy; non-small cell lung cancer; radiomics.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

Cited by

References

    1. Siddiqui F, Vaqar S, Siddiqui AH. Lung Cancer. Treasure Island (FL): StatPearls Publishing; (2022) 2022. - PubMed
    1. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA-Cancer J Clin (2023) 73(1):17–48. doi: 10.3322/caac.21763 - DOI - PubMed
    1. Azzouqa AG, Chen RQ, Lou YY, Ailawadhi S, Manochakian R. Impact of time to treatment initiation (Tti) on survival of patients with newly diagnosed non-small cell lung cancer (Nsclc). J Clin Oncol (2019) 37(15):9058. doi: 10.1200/JCO.2019.37.15_suppl.9058 - DOI
    1. Chen JW, Dhahbi J. Lung adenocarcinoma and lung squamous cell carcinoma cancer classification, biomarker identification, and gene expression analysis using overlapping feature selection methods. Sci Rep (2021) 11(1):13323. doi: 10.1038/s41598-021-92725-8 - DOI - PMC - PubMed
    1. Zhou Y, Ma Y, Shi H, Du Y, Huang Y. Epidermal growth factor receptor T790m mutations in non-small cell lung cancer (Nsclc) of Yunnan in Southwestern China. Sci Rep (2018) 8(1):15426. doi: 10.1038/s41598-018-33816-x - DOI - PMC - PubMed

Publication types

MeSH terms

Substances